1. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. (11th February 2005) Authors: Costa, F; Mumolo, M G; Ceccarelli, L; Bellini, M; Romano, M R; Sterpi, C; Ricchiuti, A; Marchi, S; Bottai, M Journal: Gut Issue: Volume 54(2005)Supplement 3 Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Design of a care pathway for Hepatitis C: a pilot study with three University Hospitals from Tuscany: Ilaria Corazza. (25th October 2022) Authors: Corazza, I; Ceccarelli, L; Moretti, G; Tavoschi, L; Vainieri, M Journal: European journal of public health Issue: Volume 32(2022)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Flu vaccination coverage in healthcare workers during a 3-year period in the context of the pandemic: Giuditta Scardina. (25th October 2022) Authors: Scardina, G; Ceccarelli, L; Casigliani, V; Mazzilli, S; Padovan, M; Petillo, A; Tavoschi, L; Foddis, R; Privitera, G; Baggiani, A Journal: European journal of public health Issue: Volume 32(2022)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P033 The assessment of serum cytokines at baseline could predict mucosal healing in patients with Crohn's disease treated with ustekinumab. A prospective study. (30th January 2023) Authors: Bertani, L; Antonioli, L; Fornili, M; D'Antongiovanni, V; Coppini, F; Ceccarelli, L; Carmisciano, L; Benvenuti, L; Mumolo, M G; Bottari, A; Baglietto, L; Bellini, M; Fornai, M; De Bortoli, N; Costa, F Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P416 Faecal calprotectin can predict mucosal healing in patients with inflammatory bowel diseases treated with vedolizumab: a prospective single-centre study. (25th January 2019) Authors: Bertani, L; Ceccarelli, L; Mumolo, M G; Tedeschi, R; Albano, E; Tapete, G; Baiano Svizzero, G; De Bortoli, N; Ricchiuti, A; Bellini, M; Marchi, S; Costa, F Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P454 Serum oncostatin M predicts mucosal healing in Crohn's disease patients treated with infliximab. (15th January 2020) Authors: Bertani, L; Antonioli, L; Fornili, M; Fornai, M; Tapete, G; Albano, E; Baiano Svizzero, G; Ceccarelli, L; Mumolo, M G; Baglietto, L; Marchi, S; Blandizzi, C; Costa, F Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 1 Page Start: S406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P506 The Impact of Anxiety in Patients With Inflammatory Bowel Diseases Treated With Biologics during COVID Lockdown. A Comparative Study between Hospitalized and non-hospitalized patients. (27th May 2021) Authors: Bertani, L; Barberio, B; Zanzi, F; Maniero, D; Ceccarelli, L; Marsilio, I; Minciotti, M; Coppini, F; Lorenzon, G; Mumolo, M G; Zingone, F; Costa, F; Savarino, E V Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S487 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P576 Therapeutic drug monitoring as predictive marker of mucosal healing in Crohn's disease patients treated with anti-TNF: a prospective multi-centre study. (25th January 2019) Authors: Bertani, L; Bodini, G; Mondello, G; Mumolo, M G; Maltinti, S; Baldissarro, I; Tapete, G; Albano, E; Ceccarelli, L; Crespi, M; Savarino, V; Marchi, S; Costa, F Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S402 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P678 Ustekinumab therapy improves the nutritional status in patients with Crohn's Disease. A prospective study. (30th January 2023) Authors: Bertani MD, L; D'Alessandro, C; Fornili, M; Coppini, F; Zanzi, F; Carmisciano, L; Geri, F; Baiano Svizzero, G; Ceccarelli, L; Mumolo, M G; Baglietto, L; Bellini, M; Costa, F; De Bortoli, N Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i810 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P709 Early measurement of serum cytokines as predictor of clinical and endoscopic outcome to vedolizumab in patients with ulcerative colitis. (25th January 2019) Authors: Bertani, L; Antonioli, L; Baglietto, L; Tapete, G; Albano, E; Mumolo, M G; Ceccarelli, L; Maltinti, S; Fornai, M; Marchi, S; Blandizzi, C; Costa, F Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗